Company / AR per Share
Sarepta Therapeutics AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$4.11
FY2025
5-year range
$1.93 / $6.42
FY2021-FY2025
Trend
-36.0%
vs FY2024
Sector context
#26 of 113
Health Care
What the data says
Sarepta Therapeutics's ar per share of $4.11 is higher than 77% of companies in the Health Care sector (FY2025). Declined from $4.55 to $4.11 over the past 2 years.
Based on SEC 10-K filings.
4.11 in FY2025 with a 5-year CAGR of +25.0%. Top quartile in the Health Care sector.
Declined from $4.55 to $4.11 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +18.6%
- 5-Year CAGR
- +25.0%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 113This company $4.11 Sector average $28.83
▼
-85.7% below sector average
Key checks
Key Insights
- In FY2025, ar per share decreased 36.0% year-over-year.
- Ranks #26 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2024.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.11 | -36.0% |
| FY2024 | $6.42 | +41.1% |
| FY2023 | $4.55 | +84.8% |
| FY2022 | $2.46 | +27.8% |
| FY2021 | $1.93 | +43.0% |
| FY2020 | $1.35 | +5.4% |
| FY2019 | $1.28 | +68.9% |
| FY2018 | $0.76 | +40.7% |
| FY2017 | $0.54 | +369.7% |
| FY2016 | $0.11 | +21.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026